A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00691405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: Arformoterol tartrate inhalation solution
DRUG: Arformoterol tartrate inhalation solution
DRUG: Arformoterol tartrate inhalation solution
DRUG: Placebo
DRUG: Arformoterol tartrate inhalation solution
DRUG: Arformoterol tartrate inhalation solution
DRUG: Arformoterol tartrate inhalation solution
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.